De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromesJean-Baptiste Rivière, William B. Dobyns, Diana Alcantara et al.|Nature Genetics|2012Cited by 752
Clinical management of patients with <i>ASXL1</i> mutations and Bohring–Opitz syndrome, emphasizing the need for Wilms tumor surveillanceBianca Russell, John M. Graham, Jennifer J. Johnston et al.|American Journal of Medical Genetics Part A|2015Cited by 66